Dr. David Samadi the Healer of Prostate Cancer

Dr. David Samadi heads the Urology Department at Lenox Hill Hospital in New York City, New York. Dr. Samadi helped to create robotic surgery at Lenox Hill Hospital where he serves as the Chairman. David is also an active Professor at the Hofstra School of Medicine. Dr. David Samadi is just one in a handful of U.S. surgeons trained in oncology to successfully treat prostate cancer using the advanced surgical procedures using robotic equipment.

Dr. David Samadi is touted with inventing the Samadi Modified Advanced Robotic Treatment (‘SMART’), a device used in prostate cancer surgeries. Using the SMART device has resulted in a 90% recovery rate for prostate cancer patients and they don’t have any after effects, like incontinence. The SMART surgical device to treat prostate cancer is not massed produced, instead it is advertised via word of mouth. Dr. Samadi said that men are dying of this disease at a rate that is a global threat.

Dr. Samadi reported that Mitt Romney, the 2012 Republic presidential nominee underwent a prostate surgery in the summer of 2017. The former Secretary of State Colin Powell and John Kerry who ran for the presidency in 2002, also had prostate cancer surgery. All three men came through the surgery with flying colors and with no incidence of a recurrence to-date.

Dr. David Samadi states that prostate cancer strikes men age 65 or older. All men diagnosed with this life-threatening disease should talk to a surgeon, but to ask questions first. You want to know how many prostate surgeries the surgeon has performed, their experience in this field, how many cases had their cancer return, and can men continue their sexual functions or have stable continence after a prostate is removed?

Dr. Samadi said that if a prostate cancer is localized and has not spread beyond the gland, then he recommends radiation as a treatment. Yes, many studies show that the results of prostate gland cancer are better with surgery. Dr. David Samadi recommends surgery rather than radiation therapy because the life expectancy is much better. Also, Dr. Samadi believes that with radiation therapy, there is a chance that a secondary cancer could occur in another part of the body and at this time, it is too late for a surgical procedure. Dr. David Samadi says he tells his patients that removing the prostate with surgery has a 100% survival rate. His patient’s take his advice because Dr. Samadi’s successful prostate surgical results are the highest anywhere and more

Clay Siegall’s Seattle Genetics: A Company Focused On Antibody Research

Seattle Genetics is a company that has redefined what it means to be a prominent member of the pharmaceutical industry. The company was founded by Clay Siegall and today stands as one of the top research and pharma companies in the state. Seattle Genetics has gone down the unconventional route for its research and focuses on human antibodies and using that as a way to fight a number of diseases and disorders. The company has made an incredible amount of progress since its inception and has come out with life-changing drugs that have aided people diagnosed with these disorders. The company first started its research in the field in 1998 and since then has managed to create a mark in the industry. Today, the company stands as one of the biggest biotech names in the state of Washington. Seattle Genetics currently has over nine hundred employees, with the number steadily growing each year. The company is valued at $10 billion as of July 2017.

One of the main disorders that Seattle Genetics focuses on is cancer. The company has been conducting its research to try and find a way to combat this disease that millions of people all over the world face. Through their research on antibodies, the company aims to take a new approach to cancer treatments, which is something that not a lot of research and pharmaceutical companies are currently doing. Seattle Genetics has come out with various flagship drugs that only they are allowed to produce currently. Numerous doctors all over the country now depend on Seattle Genetics to supply them with the right medicines to help treat the patients who have been diagnosed with cancer.

Clay Siegall has been the backbone and driving force of the company since its inception and is the reason that Seattle Genetics has such a big name in the industry today. Being heavily invested in the field of cancer research, Clay Siegall wanted to build a company that would take a new approach in cancer treatments. Starting up a company of this kind was not easy, and Clay Siegall had to work hard to convince potential investors to invest into the company. He also conducted numerous fundraisers and raised over a million from that alone which went towards the development of Seattle Genetics. Clay Siegall is also an incredible business mind and has been able to guide the company to a position of success in the industry.